Inventor
XU HONGJIANG
CN32 patents
⚠️ This page may combine multiple inventors who share the name “XU HONGJIANG”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
CHIA TAI TIANQING PHARMACEUTICAL GROUP CO LTD
26 patentsUS10251876B2Apr 9, 2019
Method for treating tumour, pharmaceutical composition and medicinal kit
CHIA TAI TIANQING PHARMACEUTICAL GROUP CO LTD7 citations82
US11597716B2Mar 7, 2023
N-heterocyclic five-membered ring-containing capsid protein assembly inhibitor, pharmaceutical composition thereof, and use thereof
CHIA TAI TIANQING PHARMACEUTICAL GROUP CO LTD5 citations72
US10745383B2Aug 18, 2020
1,3,5-triazine derivative and method of using same
CHIA TAI TIANQING PHARMACEUTICAL GROUP CO LTD2 citations72
US12319689B2Jun 3, 2025
Methyl- and trifluoromethyl-containing disubstituted sulfonamide selective BCL-2 inhibitor
CHIA TAI TIANQING PHARMACEUTICAL GROUP CO LTD2 citations70
US10231973B2Mar 19, 2019
Salts of quinazoline derivative and method for preparing the same
CHIA TAI TIANQING PHARMACEUTICAL GROUP CO LTD1 citations61
US12240811B2Mar 4, 2025
N-heterocyclic five-membered ring-containing capsid protein assembly inhibitor, pharmaceutical composition and uses thereof
CHIA TAI TIANQING PHARMACEUTICAL GROUP CO LTD0 citations60
US12195468B2Jan 14, 2025
TLR7 agonist for treating colorectal cancer and pharmaceutical combination thereof
CHIA TAI TIANQING PHARMACEUTICAL GROUP CO LTD0 citations60
US12128047B2Oct 29, 2024
TLR7 agonist and pharmaceutical combination thereof for treating lung cancer
CHIA TAI TIANQING PHARMACEUTICAL GROUP CO LTD0 citations60
US12116356B2Oct 15, 2024
N-heterocyclic five-membered ring-containing capsid protein assembly inhibitor, pharmaceutical composition thereof, and use thereof
CHIA TAI TIANQING PHARMACEUTICAL GROUP CO LTD0 citations60
US10570141B2Feb 25, 2020
Substituted pyrrolopyrimidine CDK inhibitor, pharmaceutical composition containing same and use thereof
CHIA TAI TIANQING PHARMACEUTICAL GROUP CO LTD1 citations60
US12508258B2Dec 30, 2025
Quinoline derivative for treating rheumatoid arthritis
CHIA TAI TIANQING PHARMACEUTICAL GROUP CO LTD0 citations59
US11773079B2Oct 3, 2023
Crystalline forms of 4-(tert-butoxyamino)-6-(6-(trifluoromethyl)pyridin-2-yl)-N-(2-(trifluoromethyl)pyridin-4-yl)-1,3,5-triazin-2-amine
CHIA TAI TIANQING PHARMACEUTICAL GROUP CO LTD0 citations56
US11021464B2Jun 1, 2021
Crystalline forms of 4-(tert-butoxyamino)-6-(6-(trifluoromethyl)pyridin-2-yl)-N-(2-(trifluoromethyl)pyridin-4-yl)-1,3,5-triazin-2-amine methanesulfonic acid salt
CHIA TAI TIANQING PHARMACEUTICAL GROUP CO LTD0 citations56
US10035792B2Jul 31, 2018
Resorcinol derivative as HSP90 inhibitor
CHIA TAI TIANQING PHARMACEUTICAL GROUP CO LTD1 citations52
US12336996B2Jun 24, 2025
Drug combination containing TLR7 agonist
CHIA TAI TIANQING PHARMACEUTICAL GROUP CO LTD0 citations50
US11572372B2Feb 7, 2023
Anti-HBVtetrahydroisoxazolo[4,3-c]pyridine compounds
CHIA TAI TIANQING PHARMACEUTICAL GROUP CO LTD0 citations50
US10858340B2Dec 8, 2020
Crystal of salt of quinazoline derivative
CHIA TAI TIANQING PHARMACEUTICAL GROUP CO LTD0 citations50
US10329277B2Jun 25, 2019
N-(2-((2-(dimethylamino)ethyl)(methyl)amino)-4-methoxy-5-((4-(3-methyl-2-OXO-2,3-dihydro-1h-benzo[d]imidazol-1-yl)pyrimidin-2-yl)amino)phenyl)acrylamide hydrochloride as an inhibitor of epidermal growth factor receptor activity
CHIA TAI TIANQING PHARMACEUTICAL GROUP CO LTD0 citations50
US12371431B2Jul 29, 2025
Trifluoromethyl-substituted sulfonamide as BCL-2-selective inhibitor
CHIA TAI TIANQING PHARMACEUTICAL GROUP CO LTD0 citations48
US11534398B2Dec 27, 2022
Inhaled preparation of isoglycyrrhizic acid or salt thereof, and use in preparing drugs for treating respiratory system diseases
CHIA TAI TIANQING PHARMACEUTICAL GROUP CO LTD0 citations48
US11396503B2Jul 26, 2022
Sulfonyl substituted bicyclic compound which acts as ROR inhibitor
CHIA TAI TIANQING PHARMACEUTICAL GROUP CO LTD0 citations48
US12030880B2Jul 9, 2024
Iminosulfanone compound as bromodomain protein inhibitor and pharmaceutical composition and medical use thereof
CHIA TAI TIANQING PHARMACEUTICAL GROUP CO LTD0 citations47
US11466024B2Oct 11, 2022
Bicylic compound acting as an inhibitor
CHIA TAI TIANQING PHARMACEUTICAL GROUP CO LTD0 citations47
US11891405B2Feb 6, 2024
Furo[3,4-b]pyrrole-containing BTK inhibitor
CHIA TAI TIANQING PHARMACEUTICAL GROUP CO LTD0 citations45
US10829492B2Nov 10, 2020
Amino pyrazolopyrimidine compound used as neurotrophic factor tyrosine kinase receptor inhibitor
CHIA TAI TIANQING PHARMACEUTICAL GROUP CO LTD0 citations39
US10766912B2Sep 8, 2020
Silicon-containing compound for resistance to hepatitis C virus infection
CHIA TAI TIANQING PHARMACEUTICAL GROUP CO LTD0 citations34